Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Contineum Therapeutics is a biopharmaceutical company focused on developing small molecule therapies for neuroinflammatory and neuroimmune diseases. Its portfolio includes drug candidates targeting pathways involved in conditions like pulmonary fibrosis, multiple sclerosis, and chronic pain. The company emphasizes innovative, selective compounds with potential for broad applicability, leveraging internal discovery and strategic collaborations to address significant unmet medical needs in neurology and fibrosis.
This description was generated via AI from an annual report. Updated about 1 year ago.